Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models

PURPOSE: Anticancer drug development is inefficient, but genetically engineered murine models (GEMM) and orthotopic, syngeneic transplants (OST) of cancer may offer advantages to in vitro and xenograft systems. EXPERIMENTAL DESIGN: We assessed the activity of 16 treatment regimens in a RAS-driven, I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Roberts, Patrick J., Usary, Jerry E., Darr, David B., Dillon, Patrick M., Pfefferle, Adam D., Whittle, Martin C., Duncan, James S., Johnson, Soren M., Combest, Austin J., Jin, Jian, Zamboni, William C., Johnson, Gary L., Perou, Charles M., Sharpless, Norman E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3715399/
https://ncbi.nlm.nih.gov/pubmed/22872574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-0563
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados